AeroSafe Global + BioCareSD: Scaling Specialty Pharmaceutical Delivery Across a 48-State Network
THE PROBLEM
BioCareSD faced the dual pressure of delivering time-critical therapies at scale while battling the limitations of legacy "Styrofoam-and-ice" logistics. To bridge the gap between "delivery" and "assurance," they defined five non-negotiable requirements for a new partner:
- Integrity: Guaranteed temperature stability regardless of carrier delays or extreme weather.
- Scale: A consistent, 48-state solution deployable without operational friction.
- Visibility: A shift from reactive tracking to proactive, data-driven management.
- Sustainability: Reducing packaging waste without compromising performance or TCO.
- Patient-Centricity: A partner who treats every shipment as a life-saving therapy.
The industry's legacy approach: single-use Styrofoam packaging, fragmented vendor relationships, and reactive tracking, was not built for this level of complexity, value, or accountability.
THE ACTION
AeroSafe Global transitioned BioCareSD to a fully integrated Cold Chain as a Service (CCaaS) model, replacing legacy Styrofoam with advanced insulation derived from NASA-pioneered technology. This high-performance hardware—capable of maintaining temperature for up to 72+ hours—is supported by a global closed-loop reverse-logistics infrastructure that achieved a 98.7% return rate and 75+ reuses per container. To ensure total oversight, AeroSafe deployed the AI-enabled Delivery Intelligence Navigator™, providing comprehensive visibility and dynamic intelligence through a continuous stream of integrated shipment data. By integrating real-time carrier signals for location and calculating thermal load temperature exposure each hour, the platform shifted BioCareSD’s operations from reactive troubleshooting to proactive, AI-driven risk prevention before shipments ever reach the patient.
"Our partnership with AeroSafe Global has reimagined what ‘assurance’ means in the cold chain. By replacing legacy Styrofoam with advanced packaging and efficiency-driven logistics, we’ve ensured that 100% of our shipments reach patients at the precise temperature required. With a 97% next-day arrival rate and a 99.4% container recovery rate, we are outpacing industry standards for both speed and sustainability. We’ve eliminated operational complexity for our providers while guaranteeing uninterrupted care for our most vulnerable patients.”
Bill Shirey | BioCareSD
Chief Operating Officer
THE IMPACT
In 2025, the AeroSafe-BioCareSD partnership achieved a zero-failure delivery model across a 48-state network, moving 155,000 shipments to 1,200+ sites with 0 cold-chain excursions.
For Patients & Providers
- Guaranteed Integrity: 100% of therapies arrived at temperature, ensuring uninterrupted treatment for critical oncology and retina patients.
- Speed & Reliability: Achieved a 97% next-business-day arrival rate, significantly outpacing the industry standard of 94.5%.*
- Operational Ease: Eliminated provider-side packaging complexity with a streamlined, hassle-free return process.
- Enhanced Trust: Total transparency from the warehouse to the point of care.
For BioCareSD as an Organization
- Sustainable Logistics: Achieved total elimination of single-use packaging waste through a 99.4% container return rate. This exceptional recovery allows each container to be reused over 100 times, exceeding industry standard of 85% and the AeroSafe benchmark of 98.7%.
- Scalable Infrastructure: Seamlessly supporting major 2026 expansions in retina and oncology categories.
- Revenue Growth: High-reliability distribution is a key driver for a projected 19% revenue increase in 2026.
______________________________________________________________
About BioCareSD
For nearly 50 years, BioCare has focused exclusively on advancing specialty healthcare. Through BioCareSD, the organization has reimagined what specialty distribution should be—delivering reliable, timely access to therapies for rare, ultra‑rare, and complex conditions through a purpose‑built, high‑touch model designed around manufacturer partners and customers.
Rooted in timeless service values and elevated by modern, future‑ready infrastructure, BioCareSD brings together operational rigor, technological sophistication, and consultative partnership to remove barriers and support uninterrupted patient care. Its singular focus on specialty distribution enables alignment, agility, and clarity in a complex and evolving market.
Through LogiCare3PL, BioCare extends this commitment with specialized third‑party logistics services, including temperature‑controlled warehousing, regulatory and compliance support, licensing, financial services, and data‑driven insight—designed to protect product integrity and support the unique demands of specialty supply chains.
BioCare supports manufacturers, providers, and patients with solutions built for today and designed for what’s next.
About AeroSafe Global
AeroSafe Global stands at the forefront of the industry, providing tech-driven solutions that simplify the intersection of complex logistics and pharmaceutical distribution. Through its proprietary "Cold Chain as a Service" (CCaaS) model, AeroSafe provides a seamless, end-to-end ecosystem that ensures the safe delivery of temperature-sensitive therapies to patients and providers worldwide.
Spanning 80 countries and the capacity to deliver 11 million shipments annually, AeroSafe Global’s Delivery Intelligence Navigator™ sets a new benchmark for the industry by providing the predictive visibility and real-time data integration required by specialty distributors, pharmaceutical manufacturers, modern health systems, specialty pharmacies, and direct-to-patient programs.
By integrating these digital insights with advanced packaging technology leveraged by organizations including NASA and a comprehensive full-cycle reuse program, AeroSafe Global enables a zero-failure delivery model that reduces operational costs and environmental impact while guaranteeing the integrity of every shipment.
For more information, visit BioCare or AeroSafe Global.
Related Article

Aerosafe & MD Logistics – A Sustainable Partnership: How Full-Cycle Reuse Model Reduces Product Loss and Simplified 3PL Integration
THE PROBLEM BioCareSD faced the dual pressure of delivering time-critical therapies at scale while battling the limitations of legacy "Styro …

The Last Mile Has Moved. It's Now a Patient Care Imperative.
THE PROBLEM BioCareSD faced the dual pressure of delivering time-critical therapies at scale while battling the limitations of legacy "Styro …

Reframe Pharma Last Mile as the First Moment of Care: From Outdated Systems to Delivery Intelligence
THE PROBLEM BioCareSD faced the dual pressure of delivering time-critical therapies at scale while battling the limitations of legacy "Styro …